Contracting office · 75N930

National Institutes of Health Niaid

National Institutes of Health · Department of Health and Human Services

At a glance

  • 796 active contracts, $3.41B
  • 36% of its 3,496 competed contracts drew a single offer (last 3 years)
  • Usually buys through: Multiple-award IDIQ

Money by year

  • FY2023$918.97M
  • FY2024$948.54M
  • FY2025$657.37M
  • FY2026$592.54M

Obligations (money committed) in prime awards, from USAspending.gov.

Contracts ending in the next 12 months

210 contracts, $4.47B with options. The largest:

ContractIncumbentEndsValue with options
75N93020C00002
DATA MANAGEMENT AND DATA WAREHOUSING
The Emmes Company, LLC2026-10-14$14.19M
75N93024C00001
BIOLOGICAL AND EMERGING INFECTIONS RESEARCH RESOURCES PROGRAM (BEI-RRP)
American Type Culture Collection2026-10-15$334.26M
75N93023F00001
MAINTENANCE AND SUPPORT FOR PALO ALTO FIREWALLS - ANNUAL MAINTENANCE AND SUPPORT, PLUS TWO ADDITIONAL OPTION YEARS FOR PALO ALTO EQUIPMENT
Synergy Group JV, LLC2026-10-24$6.52M
75N93025C00025
TO DEVELOP AN INTEGRATED DIAGNOSTIC PLATFORM THAT UTILIZES WHOLE GENOME SEQUENCING (WGS) TO IDENTIFY BACTERIAL PATHOGENS AND PREDICT ANTIBIOTIC SUSCEPTIBILITY DIRECTLY FROM BLOOD, WITHIN A FEW HOURS - ADDRESSING LIMITATIONS WITH CURRENT CULTURE-BASED
Genomic Labs LTD2026-10-28$3.49M
75N93022F00001
CONDUCT STUDY P217
The Administrators of Tulane Educational Fund2026-10-30$1.80M
75N93022C00001
REGULATORY MANAGEMENT CENTER (RMC)
PPD Development LP2026-10-31$29.12M
75N93019F00131
THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION.
University of Alabama at Birmingham2026-10-31$12.24M
75N93022F00001
ABL MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES
Advanced Bioscience Laboratories, Inc.2026-10-31$3.75M
75N93023C00049
SBIR PHASE II
Qoolabs Inc2026-10-31$1.50M
75N93020C00001
THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH
The Johns Hopkins University2026-11-14$25.18M

All of them, with filters →

Open notices

None open right now. Set an alert for the next one.

From USAspending.gov prime awards and SAM.gov notices. Sources and limits